Top Software Companies in Raleigh, NC (261)

Strong Revenue Growth: Revenue is rising across 2025 and into 2026, with Galleri driving year-over-year increases and volumes outpacing revenue. Feedback suggests growth accelerated in early 2026 as test adoption broadened.

Strategic Partnerships: Partnerships such as Epic EHR integration and a collaboration with Samsung for Asia expansion are expanding distribution and market access. These relationships also support commercialization through employers, health systems and digital-health channels.

Investor Backing & Capital Strength: A sizable cash balance and recent equity financing provide a substantial runway to fund R&D and commercial expansion. This capital position helps buffer the costs of scaling while regulatory review proceeds.

Strong Revenue Growth: Revenue is rising at a low-double-digit pace, with FY 2025 up 14% and Q1–Q2 2026 growing 15% and 13% year over year. Evidence indicates this marked a second consecutive year of double-digit annual growth with continued momentum into 2026.

Profitability: Profitability expanded faster than sales in 2025, with adjusted EBITDA up 25% and GAAP net income from continuing operations up 53%. This pattern points to improved operating leverage, even as quarterly results vary.

Market Expansion: International and dealer-network metrics show expansion, with total paying dealers up about 5% and international dealers up 11% year over year; international revenue rose 28% in Q2 2026. These gains suggest growth beyond the U.S. base and higher monetization per dealer.

Profitability: Operating earnings and margins improved notably in 2026, with Q3 operating earnings up sharply year over year and the operating margin rising to 5.6%. Feedback suggests earnings resilience is being supported by operational changes and a shifting business mix.

Strong Revenue Growth: Reported annual revenue expanded from $226.6B in 2023 to $270.6B in 2025, including roughly 12% growth in 2024 and 7% in 2025. This establishes a robust multi‑year revenue trajectory even as recent growth rates have moderated.

Cost & Operational Efficiency: Cost controls and operational improvements are described as lifting earnings despite lower revenue in 2026. Optum Health’s operating earnings rose from $41M to $735M year over year while serving fewer value‑based patients, indicating stronger execution.

Strong Revenue Growth: Historical 2022 results showed robust year-over-year expansion, and leadership later indicated the business was heading toward about $2 billion in revenue. These signals indicate meaningful scale and ongoing momentum.

Innovation-Driven Growth: AI product adoption and platform usage have surged since 2023, with a sizable share of customers upgrading to new AI capabilities. Company disclosures describe sharp increases in monthly active AI users and total interactions analyzed on the platform.

Market Expansion: Completion of the $6.75B Press Ganey Forsta acquisition broadens reach into healthcare experience data, relationships, and analytics. This materially expands the company’s footprint and opportunities for cross-sell.

Strong Revenue Growth: Reported three-year revenue growth of 1,012% and an Inc. 5000 rank of No. 336 indicate rapid scaling, and revenue was said to have doubled in both 2023 and 2024. Together these signals point to sustained top-line momentum.

Investor Backing & Capital Strength: A $127 million Series C at a reported $1 billion valuation and total funding exceeding $250 million signal substantial capital availability. This backing supports continued product development and go-to-market investment.

Market Expansion: New hubs in Raleigh and Toronto, government-confirmed plans for roughly 291 Raleigh jobs, and rising third‑party headcount estimates point to active geographic and organizational growth. Expanding offices and staffing suggest deeper North American coverage.

Strong Revenue Growth: Revenue increased from $2.678B in 2023 to $3.053B in 2025 and continued to rise 5.2% year over year in Q2 2026, with organic growth of 6.6%.

Profitability: Adjusted EBITDA rose 20.7% in 2025 to $792M and grew 11.2% in Q2 2026, with margin expansion to about 26.8% alongside higher adjusted net income.

Market Expansion: The company is expanding its footprint through acquisitions and capacity investments, including completing the Eurofins Electrical & Electronics business in October 2026 and enlarging testing facilities.

Strong Market Position & Advantage: Celonis is repeatedly characterized as the dominant pioneer and market leader in process mining and process intelligence, with sustained recognition from Gartner, Forrester, and Everest and visibility in rankings like the Fortune Future 50 and Forbes Cloud 100. This position is reinforced by a substantial enterprise footprint, including thousands of deployments across more than 20 global locations.

Innovation-Driven Growth: The company is extending beyond traditional dashboards into operational AI, launching its Context Model, adding AI copilots, and agreeing to acquire Ikigai Labs to bolster decision intelligence. These moves signal an evolution toward automated execution and higher platform stickiness among large enterprises.

Strategic Partnerships: Integrations and collaborations with Microsoft, Oracle, AWS, and Databricks embed Celonis within major enterprise data and AI ecosystems. This ecosystem presence expands distribution paths and strengthens its role as an operational context layer for enterprise AI.

Strong Revenue Growth: Revenue is described as continuing to rise year over year, with quarterly results around $531 million and full-year totals surpassing $2 billion alongside guidance that points to further increases. Client counts and employee records managed have also expanded, reinforcing ongoing top-line momentum.

Profitability: Operating margins and cash generation are presented as strong, with robust adjusted EBITDA and solid operating cash flows accompanying growth. A substantial recurring-revenue mix supports sustained profitability.

Cost & Operational Efficiency: Emphasis on automation and internal efficiency indicates improved productivity and scalability. The company is described as doing more with a leaner team while maintaining growth.

Strong Revenue Growth: Revenue and subscription sales have grown at a double-digit pace across recent quarters and the latest fiscal year, with management raising full-year guidance. These trends point to sustained top-line momentum.

Profitability: Net income and operating income expanded significantly, with profit growth outpacing revenue in recent periods. EPS improved year over year, indicating healthy operating leverage.

Strong Market Position & Advantage: The company is widely recognized as a leader in life-sciences cloud software, with deep adoption among major pharmaceutical companies and extensive use of its Vault platform. Vertical specialization and an integrated suite underpin a durable competitive position.

Innovation-Driven Growth: Evidence indicates repeated analyst recognition in generative and agentic AI services (e.g., HFS Market Leader; ISG Leader) alongside a proprietary AAVA platform driving AI-first, platform-led engineering. Company materials and analyst mentions highlight SDLC acceleration and AI-native delivery as core differentiators.

Market Expansion: Evidence indicates rapid geographic and delivery expansion via new AI studios and hubs in the U.S., India, and the Philippines, plus ecosystem moves such as joining major partner programs. Acquisitions (e.g., Nitor, UXReactor, Moodys Northwest Consulting) further extend footprint and service capacity.

Strong Revenue Growth: Evidence indicates fast growth in GenAI-led services and rising scale, with headcount expansion into five digits by 2025 serving as a proxy for demand. Reported momentum in AI-first programs and platform-driven delivery suggests increasing commercial traction.